This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Knowing when to invest rather than save can significantly enhance your financial growth. This guide provides insights to help you decide wisely.
26,010 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
The popular image of Annaly Capital focuses on its hefty dividend. But the real investment story sits in the balance ...
When a CFO sells shares after exercising options, investors want the real story. This article explains what ambiq mic...
Wall Street’s growing short interest and heavy AI-stock bets are reshaping Bitcoin’s role in markets. Analysts say a ...
Hot IPOs spark excitement, but do they indicate a market top? This guide compares today’s IPO activity to past bubble...
Life360 faces a pivotal year in 2026. This guide breaks down what the Q1 results could reveal about growth, margins, ...
With market volatility and shifting rates, many investors wonder if they should bond your portfolio. This guide break...
On Friday, Direxion’s TECL collapsed 19.93% as XLK dropped 6.66%, illustrating how daily leverage can magnify losses ...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
June volatility has weighed on semiconductor stocks, but a window is emerging for selective buys. Here are three name...
Bitcoin, Ethereum, and XRP show renewed bullish bias after weeks of pressure, with sentiment turning positive and pri...
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...